Why the study?
Does the inhibition of PGI2 synthetase enhance the formation of white platelet thrombi in vivo?
Does the inhibition of PGI2 synthetase enhance the formation of white platelet thrombi in vivo?
Inhibition of PGI2 synthetase enhances white platelet thrombus formation, suggesting that PGI2 synthesis is responsible for the nonthrombogenicity of the endothelium.
Answers are grounded in this paper and cite their sources.
Inhibits PGI2 synthetase and enhances platelet thrombi in animals; hypothesis-generating for endothelial nonthrombogenicity, not ready for clinical translation.
Prostaglandins play an important role in platelet-vessel wall interactions. Cyclic endoperoxides PGG2 and PGH2 are transformed to PGI2 (prostacyclin) within the arterial wall. The inhibition of PGI2 synthetase results in a marked enhancement of white platelet thrombus formations. This finding suggests that the synthesis of PGI2 from PGG2 and PGH2 accounts for the nonthrombogenicity of the endothelium.
No takes yet. Share an insight, caveat, or question.
R.H. Bourgain (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: